TickerFactsScreenerDevelopers

Coherus Oncology, Inc. (CHRS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$252.54M2017: -$200.29M2018: -$159.27M2019: $28.36M2020: $154.15M2021: -$37.43M2022: -$241.12M2023: -$174.88M2024: -$20.44M2025: -$138.51M-$138.51M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$138.51M-577.7%
2024-$20.44M+88.3%
2023-$174.88M+27.5%
2022-$241.12M-544.2%
2021-$37.43M-124.3%
2020$154.15M+443.6%
2019$28.36M+117.8%
2018-$159.27M+20.5%
2017-$200.29M+20.7%
2016-$252.54M—